Results 141 to 150 of about 10,605 (184)

Influence of genetic polymorphisms on omalizumab clinical response in pediatric severe asthma: a pilot study. [PDF]

Front Pharmacol
Rottura M, Pirrotta I, Cullotta C, Marino Y, Sacco FM, Gianguzzo VM, Irrera N, Arcoraci V, Alibrandi A, Galletta F, Corso M, Leonardi S, Manti S, Pallio G.   +13 more
europepmc   +1 more source

Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab. [PDF]

Clin Cosmet Investig Dermatol
Yu L, Hu G, Zhang Q, Zhu Y, Chen L, Chen J.   +5 more
europepmc   +1 more source

Emerging and Newly Approved Therapies for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Narrative Review. [PDF]

Diseases
Asiri RS, Amer KA, Sarhan LA, Jahash NA, Alharbi RH.   +4 more
europepmc   +1 more source

Prevalence and Maintenance of Clinical Remission in Patients with Severe Uncontrolled Asthma Undergoing Biologic Therapies. [PDF]

Open Respir Arch
Dorado-Fonseca E, García de Pedro J, Ji Z, Recio-Moreno B, de Miguel-Rodríguez L, Buendía-García MJ, de Miguel-Díez J.   +6 more
europepmc   +1 more source

From FEV₁ to Small Airways: AMethodological Review of Lung Function Assessment in Biologic-Treated Asthma. [PDF]

J Asthma Allergy
Yang HL, Chen YJ, Mai XQ, Zou XL, Ding W, Wu SZ.   +5 more
europepmc   +1 more source

A Meta-Analysis of Anti-Thyroid Peroxidase Antibody and Omalizumab Response in Chronic Spontaneous Urticaria. [PDF]

Clin Exp Allergy
Lee JH, Geum MJ, Kim DY, Ah YM, Yu YM.
europepmc   +1 more source

Successful treatment of severe influenza-associated pulmonary aspergillosis with invasive tracheobronchitis and bronchial asthma using combination antifungals and omalizumab: A case report. [PDF]

IDCases
Du W, Lv H, Ni Y, Ding Y.
europepmc   +1 more source

Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study. [PDF]

World Allergy Organ J
Li L, Xu Y, Bian S, Pan Z, Guan K.
europepmc   +1 more source

Update on Pediatric asthma management: Recent advances. [PDF]

Pediatr Allergy Immunol
Dhochak N, Robinson PFM, Saglani S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Omalizumab

Drugs, 2001
* Omalizumab is a recombinant humanised monoclonal antibody which specifically binds to the C epsilon3 domain of immunoglobulin (Ig) E, the site of high-affinity IgE receptor binding. * Improvements in asthma symptoms and health-related quality-of-life, and a significant reduction in the frequency of asthma exacerbations were seen in allergic asthmatic
S, Easthope, B, Jarvis
openaire   +2 more sources